EP
Eversept Partners’s HCA Healthcare HCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Sell |
99,983
-52,519
| -34% | -$20.1M | 3.52% | 6 |
|
|
2025
Q1 | $52.7M | Sell |
152,502
-23,306
| -13% | -$8.05M | 5.35% | 3 |
|
|
2024
Q4 | $52.8M | Buy |
175,808
+46,724
| +36% | +$14M | 4.68% | 5 |
|
|
2024
Q3 | $52.5M | Sell |
129,084
-6,396
| -5% | -$2.6M | 3.59% | 11 |
|
|
2024
Q2 | $43.5M | Buy |
135,480
+31,659
| +30% | +$10.2M | 2.98% | 10 |
|
|
2024
Q1 | $34.6M | Sell |
103,821
-10,984
| -10% | -$3.66M | 2.31% | 10 |
|
|
2023
Q4 | $31.1M | Buy |
114,805
+4,732
| +4% | +$1.28M | 2.73% | 10 |
|
|
2023
Q3 | $27.1M | Buy |
110,073
+29,348
| +36% | +$7.22M | 2.29% | 7 |
|
|
2023
Q2 | $24.5M | Buy |
80,725
+52,816
| +189% | +$16M | 2.05% | 13 |
|
|
2023
Q1 | $7.36M | Buy |
+27,909
| New | +$7.36M | 0.51% | 32 |
|
|
2022
Q2 | – | Sell |
-111,440
| Closed | -$27.9M | – | 76 |
|
|
2022
Q1 | $27.9M | Buy |
111,440
+62,346
| +127% | +$15.6M | 2.14% | 14 |
|
|
2021
Q4 | $12.6M | Buy |
49,094
+10,728
| +28% | +$2.76M | 0.81% | 26 |
|
|
2021
Q3 | $9.31M | Buy |
38,366
+30,052
| +361% | +$7.29M | 0.64% | 36 |
|
|
2021
Q2 | $1.72M | Sell |
8,314
-77,095
| -90% | -$15.9M | 0.11% | 56 |
|
|
2021
Q1 | $16.1M | Buy |
85,409
+68,655
| +410% | +$12.9M | 1.21% | 25 |
|
|
2020
Q4 | $2.76M | Sell |
16,754
-35,646
| -68% | -$5.86M | 0.32% | 38 |
|
|
2020
Q3 | $6.53M | Buy |
52,400
+22,000
| +72% | +$2.74M | 1.45% | 21 |
|
|
2020
Q2 | $2.95M | Sell |
30,400
-70,600
| -70% | -$6.85M | 0.4% | 35 |
|
|
2020
Q1 | $9.07M | Buy |
+101,000
| New | +$9.07M | 2.26% | 13 |
|